Skip to main content
DNA Labs India

G6PC2 Gene Hyperinsulinaemia, association with, G6PC2 related NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

G6PC2 Gene Hyperinsulinaemia, association with, G6PC2 related NGS Genetic Test

Short Name: G6PC2 NGS Genetic Test

Also known as: G6PC2 Gene Mutation Test, G6PC2 Hyperinsulinism Genetic Test, G6PC2 Next Generation Sequencing Test, Congenital Hyperinsulinism G6PC2 Panel, G6PC2 DNA Sequencing Test

G6PC2 Gene Hyperinsulinaemia, association with, G6PC2 related NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Sanger Confirmation of Variants, Bioinformatic Analysis on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.. Free home collection in 300+ cities across India.

NGS Genetic TestUnisexAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the G6PC2 gene that are associated with hyperinsulinaemia. It aids in confirming a clinical diagnosis, differentiating G6PC2-related hyperinsulinaemia from other forms of congenital hyperinsulinism, guiding treatment decisions, facilitating carrier testing in family members, and providing information for genetic counselling and family planning.

Test Code
2079
CPT Code
81479
ICD Code
E16.1
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Sanger Confirmation of Variants, Bioinformatic Analysis
Step 1

Sample Collection

No special preparation or fasting is required. Ensure that the patient has not received a blood transfusion within the past 4 weeks. Provide complete clinical history and family pedigree information prior to sample collection.

Method: Venipuncture or FTA Card finger-prick

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of venous blood in an EDTA (lavender-top) tube under aseptic conditions. Alternatively, one drop of blood on an FTA card is accepted. The sample is labelled with patient details and stored at ambient temperature.

Step 3

Report Delivery

The sample is transported to the laboratory at ambient room temperature. Genetic counselling is recommended post-collection to discuss expected findings, potential outcomes, and implications of the test results.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.

Patient Instructions

1
Before the Test:No fasting is required before sample collection. Provide your complete medical history, family history of metabolic disorders, and any prior genetic test reports. A genetic counselling session is recommended prior to testing to discuss the implications of potential results and to draw a pedigree chart of affected family members.
2
During the Test:A blood sample (3-5 mL) will be drawn from a vein in your arm by a trained phlebotomist. Alternatively, a finger-prick blood sample may be collected on an FTA card. The procedure typically takes less than 10 minutes and involves minimal discomfort.
3
After the Test:After sample collection, you may resume normal activities immediately. The sample is processed in the laboratory using Next-Generation Sequencing technology. Results are typically available within 3-4 weeks. A genetic counselling session post-testing is recommended to interpret and discuss the results.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the G6PC2 gene that are associated with hyperinsulinaemia. It aids in confirming a clinical diagnosis, differentiating G6PC2-related hyperinsulinaemia from other forms of congenital hyperinsulinism, guiding treatment decisions, facilitating carrier testing in family members, and providing information for genetic counselling and family planning.

How to Prepare

  • Collect 3-5 mL venous blood in an EDTA (lavender-top) tube.
  • Alternatively, place one drop of blood on an FTA card and allow to dry completely.
  • Label the sample clearly with patient name, date of birth, and sample ID.
  • Transport the sample at ambient room temperature (15-30°C).
  • Do not freeze the blood sample prior to DNA extraction.
  • Include completed test requisition form with clinical history and family pedigree.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"G6PC2 gene variants have been associated with variations in fasting glucose levels and insulin secretion. Genetic testing through NGS allows precise identification of pathogenic or likely pathogenic variants, which is essential for clinical management of patients with unexplained hyperinsulinaemia. Early genetic diagnosis can guide targeted treatment strategies and facilitate informed family planning decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL EDTA whole blood or 2-5 µg extracted DNA
ContainerEDTA (Lavender Top) tube or FTA Card
Collection MethodVenipuncture or FTA Card finger-prick

Sample Stability

EDTA whole blood at ambient temperature (15-30°C)
Extracted DNA at 2-8°C
Extracted DNA at -20°C
FTA Card (dried blood spot)
Sample Rejection Criteria:
  • Clotted blood sample collected in EDTA tube
  • Heavily haemolysed or lipaemic sample
  • Sample with insufficient volume (< 2 mL)
  • Unlabelled or mislabelled sample
  • Sample received without completed requisition form
  • Sample collected within 4 weeks of a blood transfusion

Understanding Your Results

The results of the G6PC2 NGS Genetic Test are interpreted by a qualified clinical geneticist. A positive result indicates the identification of one or more pathogenic or likely pathogenic variants in the G6PC2 gene that are consistent with a diagnosis of G6PC2-related hyperinsulinaemia. A negative result means no pathogenic variants were detected in the G6PC2 gene, though this does not entirely exclude a genetic basis for the patient's condition. Variants of uncertain significance (VUS) may be reported and require correlation with clinical findings and family studies.
📊

One or more pathogenic or likely pathogenic variants were identified in the G6PC2 gene. This is consistent with G6PC2-related hyperinsulinaemia. Clinical correlation and genetic counselling are strongly recommended. Family cascade testing may be indicated.

Confirms diagnosis of G6PC2-related hyperinsulinaemia

Result type: Pathogenic Variant Detected

📊

No pathogenic or likely pathogenic variants were identified in the G6PC2 gene. This result does not completely rule out a genetic cause for the patient's clinical presentation, as other genes may be involved.

G6PC2-related hyperinsulinaemia is unlikely; consider alternative genetic or non-genetic causes

Result type: No Pathogenic Variant Detected

📊

A variant of uncertain significance was detected. The clinical relevance of this variant cannot be determined at this time. Additional family studies and functional analyses may be needed to clarify pathogenicity.

Requires clinical correlation, follow-up, and possible reclassification over time

Result type: Variant of Uncertain Significance (VUS)

📊

A single heterozygous pathogenic variant was identified, consistent with carrier status. Genetic counselling is recommended for family planning implications.

Individual is a carrier; risk of affected offspring if partner is also a carrier

Result type: Carrier Status Identified

⚠️ When to Consult a Doctor:

Consult a doctor or genetic counsellor if you or your child experiences recurrent episodes of low blood sugar, unexplained fatigue, excessive sweating, seizures, or if there is a known family history of hyperinsulinaemia or congenital hyperinsulinism. If your test result is positive or reveals a variant of uncertain significance, seek genetic counselling to understand the implications and plan appropriate management.

Limitations

  • This test does not detect large structural rearrangements beyond the analytical sensitivity of NGS.
  • Variants of uncertain significance (VUS) may be identified that cannot be definitively classified at the time of reporting.
  • Deep intronic variants outside the targeted region and regulatory region mutations may not be detected.
  • This test does not assess for epigenetic changes or methylation abnormalities in the G6PC2 gene.
  • A negative result does not exclude other genetic or non-genetic causes of hyperinsulinaemia.

Risks & Considerations

  • Minor bruising or discomfort at the blood draw site
  • Extremely rare risk of infection at the puncture site
  • Emotional or psychological impact of genetic test results
  • Potential identification of variants of uncertain significance that may cause anxiety

Interfering Factors

  • Degraded or insufficient DNA quality from the submitted sample
  • Recent blood transfusion within the past 4 weeks may affect results
  • Concurrent use of high-dose biotin supplements may interfere with certain downstream assays
  • Sample contamination during collection or transport

Compare With Similar Tests

TestG6PC2 Gene Hyperinsulinaemia, association with, G6PC2 related NGS Genetic TestABCC8 Gene NGS TestKCNJ11 Gene NGS TestComprehensive Hyperinsulinism Gene Panel
ComparisonG6PC2 Gene Hyperinsulinaemia, association with, G6PC2 related NGS Genetic Test

Frequently Asked Questions

What is G6PC2-related hyperinsulinaemia?
G6PC2-related hyperinsulinaemia is a rare genetic condition caused by mutations in the G6PC2 gene, which encodes glucose-6-phosphatase catalytic subunit 2 in pancreatic beta cells. These mutations can alter insulin secretion, leading to abnormally high insulin levels in the blood, which may cause hypoglycaemia (low blood sugar) and related symptoms.
What are the common symptoms of G6PC2 Gene Hyperinsulinaemia?
Symptoms can include recurrent episodes of low blood sugar (hypoglycaemia), fatigue, excessive sweating, weight gain, blurred vision, excessive thirst (polydipsia), excessive urination (polyuria), and in severe cases, seizures or loss of consciousness. Some individuals may be asymptomatic or have mild symptoms.
What is the G6PC2 related NGS Genetic Test?
The G6PC2 related NGS Genetic Test is a specialised genetic test that uses Next-Generation Sequencing (NGS) technology to comprehensively analyse the G6PC2 gene for mutations associated with hyperinsulinaemia. It can detect point mutations, small insertions, deletions, and splice-site variants with high sensitivity and specificity.
Who should get the G6PC2 related NGS Genetic Test?
This test is recommended for individuals with recurrent unexplained hypoglycaemia, persistent hyperinsulinaemia (especially in neonates and infants), a family history of G6PC2-related disease or congenital hyperinsulinism, and those requiring genetic counselling for family planning purposes.
What is the cost of the G6PC2 related NGS Genetic Test in India?
The cost of the G6PC2 related NGS Genetic Test at DNA Labs India is INR 20,000. This price includes home sample collection, NGS sequencing, clinical interpretation report, and raw data files (FASTQ and VCF). Free home sample collection is available across India.
What sample is required for the G6PC2 related NGS Genetic Test?
The test requires a blood sample (3-5 mL collected in an EDTA lavender-top tube), extracted DNA, or one drop of blood on an FTA card. No fasting is required prior to sample collection.
How long does it take to receive the G6PC2 Genetic Test results?
The turnaround time for the G6PC2 related NGS Genetic Test is approximately 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.
Is home sample collection available for the G6PC2 Genetic Test?
Yes, DNA Labs India offers free home sample collection for the G6PC2 related NGS Genetic Test across major cities in India. You can book your sample collection online, and a trained phlebotomist will visit your location at a convenient time.
What files are provided with the G6PC2 Genetic Test report?
DNA Labs India provides a comprehensive clinical test report along with Raw Data files, FASTQ files, and VCF files. DNA Labs India is the only lab in India that transparently shares all raw sequencing data with patients and their physicians for independent verification and reanalysis.
Is the G6PC2 Genetic Test covered by insurance in India?
Genetic testing coverage varies across insurance providers and policies. Currently, this test is not typically covered under government health schemes such as PMJAY, CGHS, ECHS, or ESIC. It is recommended to check with your private insurance provider for specific coverage details.
Can the G6PC2 Genetic Test be used for prenatal diagnosis?
This test is primarily designed for diagnostic purposes in symptomatic individuals. For prenatal or preimplantation genetic diagnosis, specialised testing approaches may be required. Please consult a genetic counsellor or clinical geneticist for guidance on prenatal testing options.
What should I do if my G6PC2 Genetic Test result is positive?
A positive result indicates the presence of a pathogenic or likely pathogenic variant in the G6PC2 gene. You should consult your treating physician or a genetic counsellor to understand the clinical implications, discuss treatment options, and determine if family members should undergo cascade genetic testing.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.